KNB Kanabo Group Plc
Kanabo Group Plc, a digital health company, engages in the research, development and commercialization of cannabis-derived formulations and therapeutic inhalation devices. It operates through Primary Care and Secondary Care segments. The company offers The GP Service, an online telehealth platform, that provides patients with video consultations, online prescriptions, and primary care services; and operates Treat It, an online clinic focused on management of chronic pain. It also provides cultivation consultancy for cannabis businesses, as well as develops and distributes cannabis derived medicinal and wellness products. Kanabo Group Plc was incorporated in 2016 and is based in London, the United Kingdom.…
Industry Peers
Medical Care FacilitiesKey Statistics
About Kanabo Group (LON: KNB)
›
Kanabo Group (LON: KNB) is listed on the London Stock Exchange, where its shares trade in pence sterling (GBp). It belongs to the Medical Care Facilities industry, part of the Healthcare sector, and reports about 20 employees.
The shares were at 0.0022 GBp on 18 November 2026, down 99.0% over 52 weeks. Its 52-week range is 0.0022 GBp to 0.2250 GBp, and it trades at the bottom of that range.
Its market capitalisation is 1.42M GBP.
Kanabo Group reports return on equity of -106.3%, an operating margin of -317.1% and revenue up 54.6% year over year.
It holds more cash than debt, a net cash position of 1.88M GBP. Its Piotroski F-score is 4 out of 9, an average reading of its financial health.